Anti-inflammatory therapeutics are mostly used to reduce inflammation. These drugs are types of analgesics that are used for reducing pain.Primarily, these therapeutics are used in disease conditions such as respiratory diseases, arthritis, inflammatory bowel diseases and multiple sclerosis. Anti-inflammatory therapeutics alleviate pain by counteracting the enzyme cyclooxygenase enzyme. These enzymes synthesize prostaglandins which is responsible for inflammation. These therapeutics reduce or prevent the secretion of prostaglandins and ultimately lower the severity of inflammation.

Download exclusive Brochure of this report:
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1907

Increasing incidences of atherosclerosisthat demands treatment by anti-inflammatory drugs will boost the growth of this market.In addition, the market of anti-inflammatory therapeutics experiences positive growth owing to rising launch of new drugs by key manufacturers in anti-inflammatory segments. This provides cost effective alternatives to the customers and ultimately drives the overall growth of this market. In addition, high efficacy of these products and development of emerging markets of anti-inflammatory therapeutics fuels the growth of the market. However, high incidences of unfavorable side-effects such as stomach ulcer, myocardial infarction and strokecoupled with stringent regulatory guidelines for the use of these drugs restrains the growth of this market.

The global anti-inflammatory therapeuticsmarket can be categorized as:

By Class

• Non-steroidal anti-inflammatory drugs
• Immune selective anti-inflammatory derivatives

Geographically, North America is considered to be the largest market of anti-inflammatory therapeutics,owing to the launch of new and advanced products by domiciled key players coupled with increasing uptake of these drugs by consumers. Europe is considered as a second largest market of anti-inflammatory therapeutics. The growth is mainly attributed to increasing number of cardiovascular and inflammatory diseases in this region. In addition, Asia-Pacific region is the emerging market for anti-inflammatory therapeutics because of rising healthcare awareness among the people.

Various key players contributing to the global anti-inflammatory therapeutics marketcomprises Abbott Laboratories, Amgen, Inc., Johnson & Johnson, AstraZeneca, Sanofi Aventis, Boehringer Ingelheim GmbH and others.